Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Message: The Psychedelic Diaries Podcast - #018 Anthony Tennyson: a mental health revolution

Psychedelic Diaries episode summary:

We talk with Anthony Tennyson — CEO and cofounder of Awakn Life Sciences— about seeing psychedelics through four lenses: compound, therapy, therapist, and delivery.



New Message
Please login to post a reply